Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Roforth, Matthew M ^a   Atkinson, Elizabeth J ^a   Levin, Ellis R ^b   Khosla, Sundeep ^a   Monroe, David G ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN;

ARTICLE; BONE DENSITY; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; ESTROGEN RESPONSIVE ELEMENT; FETUS; FRACTURE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MUTANT; OSTEOBLAST; RNA SEQUENCE; TRANSCRIPTION REGULATION; WILD TYPE; BONE; CELL LINE; CYTOLOGY; GENE ONTOLOGY; GENETICS; METABOLISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

BONE AND BONES; CELL LINE; ESTROGEN RECEPTOR ALPHA; GENE ONTOLOGY; HUMANS; OSTEOBLASTS; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION;

EID: 84899718963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095987     Document Type: Article

References (30)

1. Khosla S, Melton LJ 3rd, Riggs BL (2011) The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 26: 441-451.
2. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, et al. (2002) An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol 16: 2188-2201. (Pubitemid 35155533)
3. Syed FA, Fraser DG, Monroe DG, Khosla S (2011) Distinct effects of loss of classical estrogen receptor signaling versus complete deletion of estrogen receptor alpha on bone. Bone 49: 208-216.
4. Syed FA, Fraser DG, Spelsberg TC, Rosen CJ, Krust A, et al. (2007) Effects of loss of classical ERE signaling on bone in male mice. Endocrinology 148: 1902-1910. (Pubitemid 46457128)
5. Syed FA, Modder UIL, Fraser DG, Spelsberg TC, Rosen CJ, et al. (2005) Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J Bone Miner Res 20: 1992-2001. (Pubitemid 41532785)
6. Levin ER (2011) Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 25: 377-384.
7. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, et al. (2003) Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 23: 1633-1646. (Pubitemid 36246045)
8. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, et al. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541.
9. Pedram A, Razandi M, O'Mahony F, Harvey H, Harvey BJ, et al. (2013) Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling. Sci Signal 6: ra36.
10. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, et al. (2007) A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282: 22278-22288. (Pubitemid 47267344)
11. Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995) Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10: 178-186.
12. Modder UI, Rudnik V, Liu G, Khosla S, Monroe DG (2012) A DNA binding mutation in estrogen receptor-α leasts to supression of Wnt signaling via β-catenin destabilization in osteoblasts. J Cell Biochem 113: 2248-2255.
13. Fujita K, Roforth MM, Atkinson EJ, Peterson JM, Drake MT, et al. (2014) Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture. Osteoporos Int 25: 887-895.
14. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. (Pubitemid 34679544)
15. Modder UI, Roforth MM, Hoey K, McCready LK, Peterson JM, et al. (2011) Effects of estrogen on osteoprogenitor cells and cytokines/bone regulatory factors in postmenopausal women. Bone 49: 202-207.
16. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
17. Langmead B, Trapnell C, Pop M, Salzberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
18. Wang L, Wang S, Li W (2012) RSeQC: quality control of RNA-seq experiments. Bioinformatics 28: 2184-2185.
19. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
20. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, et al. (2001) Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276: 13615-13621.
21. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44: 491-501.
22. Adlanmerini M, Solinhac R, Abot A, Fabre A, Raymond-Letron I, et al. (2014) Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci USA 111: E283-290.
23. La Rosa P, Pesiri V, Leclercq G, Marino M, Acconcia F (2012) Palmitoylation regulates 17beta-estradiol-induced estrogen receptor-alpha degradation and transcriptional activity. Mol Endocrinol 26: 762-774.
24. Madak-Erdogan Z, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JA, et al. (2008) Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 22: 2116-2127.
25. Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, et al. (2005) Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell 16: 231-237. (Pubitemid 40028339)
26. Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker MG, et al. (1996) 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12: 2315-2324. (Pubitemid 26192711)
27. Razandi M, Pedram A, Rosen EM, Levin ER (2004) BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24: 5900-5913. (Pubitemid 38787974)
28. Zhang D, Trudeau VL (2006) Integration of membrane and nuclear estrogen receptor signaling. Comp Biochem Physiol A Mol Integr Physiol 144: 306-315. (Pubitemid 43956565)
29. Pedram A, Razandi M, Aitkenhead M, Levin ER (2005) Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 280: 26339-26348. (Pubitemid 41022232)
30. Pedram A, Razandi M, Narayanan R, Dalton JT, McKinsey TA, et al. (2013) Estrogen regulates histone deacetylases to prevent cardiac hypertrophy. Mol Biol Cell 24: 3805-3818.